IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 225 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,889,283 | -83.0% | 88,243 | -85.8% | 0.54% | -85.7% |
Q3 2022 | $11,131,000 | +168.5% | 620,464 | +44.0% | 3.76% | +195.1% |
Q2 2022 | $4,145,000 | +160.4% | 430,900 | +355.5% | 1.28% | +93.6% |
Q1 2022 | $1,592,000 | +226.9% | 94,600 | +215.3% | 0.66% | +139.6% |
Q3 2021 | $487,000 | -39.4% | 30,000 | -76.9% | 0.28% | -37.4% |
Q1 2021 | $804,000 | -10.6% | 130,043 | 0.0% | 0.44% | -15.9% |
Q4 2020 | $899,000 | – | 130,043 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |